semaglutide / tirzepatide Weight loss: or tirzepatide, which is better? going from tirzepatide to semaglutide

Source data are available online for this figure

BPC-157, TB-500 and NAD+ act through unrelated pathways targeting different cellular systems [2][16]

The GLP-1 obesity drug is affecting everything from public health to pharmaceutical and medical tech companies, and even the consumer sector

The following will review recent evidence, including from the FLOW and SELECT trials, disclosing benefits of GLP-1 RAs, with a particular focus on kidney disease progression and cardiovascular benefits in patients with diabetes

Katsnelson MA, Rucker LG, Russo HM, Dubyak GR

Why do most people stop taking them within months of starting